Latest News

CKD Corporation ( TSE:6407 ) investors will be delighted, with the company turning in some strong numbers with its...

On February 13, 2026, Rakus Co., Ltd. announced a share repurchase program of up to 8,800,000 shares for ¥5,000 million, alongside preliminary January 2026 consolidated sales of ¥5,247 million, very large year-on-year. An interesting element is that Rakus plans to cancel all repurchased shares rather than hold them as treasury stock, explicitly targeting higher capital efficiency and shareholder returns. We’ll now examine how this planned cancellation of repurchased shares could influence...

Recent performance puts Himax Technologies (HIMX) back on investors’ radar Himax Technologies (HIMX) has seen mixed share performance recently, with a 10.1% decline over the past month but a 7.2% gain over the past 3 months. This has prompted closer attention from investors. See our latest analysis for Himax Technologies. At a share price of US$7.72, Himax’s recent 1-month share price return of a 10.1% decline and 7.2% gain over 3 months suggest momentum has cooled in the short term...

Earlier this month, Trane Technologies announced that its Board approved a 12% increase in the quarterly dividend to US$1.05 per ordinary share (US$4.20 annualized), payable on March 31, 2026 to shareholders of record on March 6, 2026. In addition, the company is scheduled to present at the Barclays 43rd Annual Industrial Select Conference in Miami Beach on February 17, 2026, giving management a platform to explain how the higher dividend fits into its broader capital allocation and growth...

Citigroup’s fresh Buy initiation on Adecoagro (NYSE:AGRO) on February 16, 2026, paired with its Zacks Rank #1 (Strong Buy) value rating, is putting this agricultural producer squarely on many investors’ watchlists. See our latest analysis for Adecoagro. At a share price of $8.65, Adecoagro has had a mixed run. Its 30-day share price return is 5.75% and its 90-day share price return is 10.19%, while its 1-year total shareholder return shows a decline of 7.93%. This contrasts with 3-year and...

Valiant Holding (SWX:VATN) has announced an annual dividend of CHF 6.00 per share, with an ex dividend date on May 18, 2026, a record date on May 19, and payment on May 20. See our latest analysis for Valiant Holding. The dividend announcement comes as Valiant Holding’s share price has moved to CHF 162.8, with a 30 day share price return of 4.23% and a 90 day share price return of 20.06%. The 1 year total shareholder return of 52.03% and 5 year total shareholder return of 127.20% point to...

What the latest earnings and guidance mean for Phibro Animal Health (PAHC) Phibro Animal Health (PAHC) has attracted fresh attention after releasing second quarter and six month results, updating its fiscal 2026 guidance, and affirming a quarterly dividend. For investors, the combination of reported sales, earnings, and forward guidance provides a clearer snapshot of how the business is currently performing and what management expects for the rest of the fiscal year. See our latest analysis...

Ezaki Glico (TSE:2206) is in focus after activist shareholder Longchamp SICAV, represented by Dalton Investments, filed proposals that the board opposes, while the company also outlined dividends and fresh earnings guidance for 2026. See our latest analysis for Ezaki Glico. The recent governance dispute and fresh guidance have arrived at a time when momentum in Ezaki Glico's share price appears to be building, with a 30 day share price return of 10.55% and a 1 year total shareholder return of...

Why Haemonetics Stock Is Drawing Investor Attention Haemonetics (HAE) has come onto investors' radar after a sharp share price pullback, with the stock showing negative returns over the past month and past 3 months despite positive annual revenue and net income growth. See our latest analysis for Haemonetics. The recent pullback fits into a weaker trend, with a 30 day share price return of about 20% and a 3 year total shareholder return of roughly a 29% decline, suggesting momentum has been...

What the latest half year results mean for shareholders Thomson Medical Group (SGX:A50) has just posted half year numbers that show sales of S$213.08 million compared with S$199.06 million a year earlier, alongside a narrower net loss of S$10.25 million. Basic and diluted loss per share from continuing operations came in at S$0.00039, versus S$0.00049 previously. This gives you a sense of how much capital the business is currently consuming per share. See our latest analysis for Thomson...

In early February 2026, NOV Inc. reported fourth-quarter 2025 results showing quarterly revenue of US$2,277 million, a net loss of US$78 million, and US$70 million of goodwill and long-lived asset impairments, alongside guidance for a 1% to 3% year-over-year revenue decline in the first quarter of 2026. At the same time, management highlighted that tighter acquisition criteria, a completed buyback of 36,959,834 shares for US$544.64 million, and a focus on portfolio efficiency are intended to...

Denka (TSE:4061) recently reported nine-month earnings to December 31, 2025, with sales of ¥290,774 million, net income of ¥5,535 million, and basic EPS from continuing operations of ¥64.23. See our latest analysis for Denka. The earnings update appears to have supported sentiment, with a 90 day share price return of 30.86% and a 1 year total shareholder return of 54.00% suggesting momentum has picked up after a softer 30 day share price move. If Denka’s move has you thinking about where else...

Wynn Resorts (WYNN) is back in focus after its latest quarterly update, where revenue was supported by Macau operations while profits declined as Las Vegas and Boston softened and earnings missed Wall Street expectations. See our latest analysis for Wynn Resorts. At a share price of $113.39, Wynn Resorts has had a mixed start to 2026. The stock saw a 1 day share price return of 5.14% after earnings volatility, but the year to date share price return shows a 7.49% decline. Meanwhile, the 1...

Envista Holdings (NVST) has been drawing attention after recent share price moves, with the stock closing at $28.97. For investors, the question now is how this dental-focused business lines up against its fundamentals. See our latest analysis for Envista Holdings. The recent rise to a 1 month share price return of 14.78% and 90 day share price return of 51.44% comes after a weaker 3 year total shareholder return of 24.71%. This suggests momentum has picked up recently. If Envista’s move has...

Earnings upgrade and dividend move put Computershare in focus Computershare (ASX:CPU) lifted its fiscal 2026 earnings guidance after first half results, pointing to momentum across key businesses, lower interest costs and buyback benefits, while also announcing a higher ordinary franked dividend. See our latest analysis for Computershare. The upgraded guidance and dividend increase have arrived after a mixed share price patch. The 1 day share price return of 5.0% partly offsets a 30 day share...

Erasca recently presented at Guggenheim Securities’ Emerging Outlook: Biotech Summit 2026, outlining progress on its ERAS-0015 molecular glue and ERAS-4001 KRAS inhibitor programs, including early partial tumor responses without dose-limiting toxicities and Phase 1 data anticipated later in 2026. An interesting angle for investors is how ERAS-0015’s early safety and response profile, alongside plans for combination approaches, could shape perceptions of Erasca’s emerging RAS-focused...

Tokyo Century earnings put recent share moves in context Tokyo Century (TSE:8439) is back in focus after reporting nine month earnings to 31 December 2025, with sales of ¥1,040,108 million and net income of ¥115,907 million, both above the prior year. See our latest analysis for Tokyo Century. The latest nine month results have arrived alongside a strong run in the shares, with a 19.45% 90 day share price return and a 56.98% 1 year total shareholder return, suggesting momentum has been...

Why Sun Communities’ interim CFO change matters for shareholders Sun Communities (SUI) has announced that Chief Financial Officer Mark E. Patten is stepping down by mutual agreement, with long time insider Fernando Castro Caratini stepping in as interim CFO while the company reaffirms its 2025 guidance. See our latest analysis for Sun Communities. The CFO transition and reaffirmed 2025 guidance come as Sun Communities’ share price sits at $130.79, with a 7.09% year to date share price return...

It's been a good week for Rakus Co., Ltd. ( TSE:3923 ) shareholders, because the company has just released its latest...

In February 2026, Camtek Ltd. announced it had received a US$25,000,000 order for its Hawk inspection systems from a tier-1 integrated device manufacturer focused on AI applications, lifting the total value of recent Hawk orders from this customer to US$45,000,000. The order highlights how Camtek’s Hawk platform is gaining traction in advanced packaging areas such as High Bandwidth Memory, chiplets, hybrid bonding and ultra-dense micro-bump wafers, potentially broadening its role in...

Earlier this month, Keysight Technologies launched SOS Enterprise, an enhanced engineering data management platform that automates governance, traceability, and compliance to support AI adoption at scale across multi-site semiconductor and electronics development teams. By turning fragmented design files and verification data into versioned, traceable assets in a single system of record, SOS Enterprise aims to unlock reliable AI integration and IP reuse for highly regulated industries such...

In February 2026, Scotts Miracle-Gro filed a US$183.34 million shelf registration for 2,750,000 common shares tied to an ESOP-related offering and, earlier in the month, refreshed its Miracle-Gro indoor product lineup with new soils, plant foods, pest solutions, and an organic plant food item now available through major national retailers and its website. The combination of an employee-focused share program and wellness-oriented indoor gardening products underscores how Scotts Miracle-Gro is...

In early February 2026, Becton Dickinson launched cash tender offers of up to US$1.60 billion to repurchase a wide range of outstanding senior notes and also completed a US$1,307.21 million share buyback program first announced in 2021, alongside reaffirming low single-digit plus GAAP revenue growth guidance for fiscal 2026. Together with ongoing portfolio reshaping, including the planned separation of its Biosciences and Diagnostics businesses and board changes, these balance sheet moves...

In early February 2026, Bristol-Myers Squibb reported fourth-quarter 2025 revenue of US$12,502 million and net income of US$1,087 million, while confirming completion of a long-running share repurchase program totaling 475,816,819 shares for US$29,984.88 million since its announcement in October 2016. The sharp swing from a full-year 2024 net loss to a 2025 net profit of US$7.05 billion highlights how earnings have recovered even as annual revenue stayed broadly flat at about US$48.19...